Notable Analyst Rating Changes 10/15: JPM, PCG, NVLS, PRX Upgrade; BJS, BHI, SCHW, AZ, TRV, LAZ Downgrade
UPGRADES:
Fox-Pitt upgrades JPMorgan Chase (NYSE: JPM) from In-line to Outperform. Price target increased to $55 from $38.
UBS upgrades PG&E Corp (NYSE: PCG) from Neutral to Buy.
Citi upgrades Novellus (Nasdaq: NVLS) from Hold to Buy. Price target increased from $19.50 to $27.
Barclays is upgrading Per Pharmaceuticals (NYSE: PRX) to Overweight from Equal Weight with a $30 target (prev. $18). Click Here for more color.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Citi downgrades BJ Services (NYSE: BJS) from Hold to Sell. Price target lowered from $16 to $14.
Citi downgrades Baker Hughes (NYSE: BHI) from Hold to Sell. Price target $39.
BofA Merrill Lynch downgrades Charles Schwab (Nasdaq: SCHW) from Buy to Neutral. The firm maintained its $23.50 price target.
Bank of American downgrades Allianz (NYSE: AZ) from Buy to Neutral.
Keefe, Bruyette & Woods downgrades The Travelers Companies (NYSE: TRV) to Market Perform. Price target $51.
Oppenheimer downgrades Lazard Ltd (NYSE: LAZ) from Outperform to Perform. Price target $45.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Goldman Sachs resumes coverage on Human Genome Sciences, Inc. (Nasdaq: HGSI) with a Buy rating and $24 price target.
Standpoint Research initiates coverage on Wal-Mart (NYSE: WMT) with a Buy. Price target $60.
Bernstein initiates coverage on Petroleo Brasileiro (Petrobras) (NYSE: PBR) with an Outperform rating. Price target $56.
RBC initiates coverage on Weyerhaeuser (NYSE: WY) with a Sector Perform rating. Price target $38.
Susquehanna initiates coverage on NYSE Euronext (NYSE: NYX) with a Neutral rating.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Fox-Pitt upgrades JPMorgan Chase (NYSE: JPM) from In-line to Outperform. Price target increased to $55 from $38.
UBS upgrades PG&E Corp (NYSE: PCG) from Neutral to Buy.
Citi upgrades Novellus (Nasdaq: NVLS) from Hold to Buy. Price target increased from $19.50 to $27.
Barclays is upgrading Per Pharmaceuticals (NYSE: PRX) to Overweight from Equal Weight with a $30 target (prev. $18). Click Here for more color.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Citi downgrades BJ Services (NYSE: BJS) from Hold to Sell. Price target lowered from $16 to $14.
Citi downgrades Baker Hughes (NYSE: BHI) from Hold to Sell. Price target $39.
BofA Merrill Lynch downgrades Charles Schwab (Nasdaq: SCHW) from Buy to Neutral. The firm maintained its $23.50 price target.
Bank of American downgrades Allianz (NYSE: AZ) from Buy to Neutral.
Keefe, Bruyette & Woods downgrades The Travelers Companies (NYSE: TRV) to Market Perform. Price target $51.
Oppenheimer downgrades Lazard Ltd (NYSE: LAZ) from Outperform to Perform. Price target $45.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Goldman Sachs resumes coverage on Human Genome Sciences, Inc. (Nasdaq: HGSI) with a Buy rating and $24 price target.
Standpoint Research initiates coverage on Wal-Mart (NYSE: WMT) with a Buy. Price target $60.
Bernstein initiates coverage on Petroleo Brasileiro (Petrobras) (NYSE: PBR) with an Outperform rating. Price target $56.
RBC initiates coverage on Weyerhaeuser (NYSE: WY) with a Sector Perform rating. Price target $38.
Susquehanna initiates coverage on NYSE Euronext (NYSE: NYX) with a Neutral rating.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
You May Also Be Interested In
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Keefe, Bruyette & Woods, UBS, JPMorgan, Citi, Merrill Lynch, Bank of America, Lazard, Fox-Pitt Kelton, Barclays, Susquehanna International Group of Companies, Notable Analyst Rating Changes, EIM Group, Life, Style and Real EstateSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Down)